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Many studies in hypertensive humans and animals have shown
that increased blood viscosity is in direct relation with essential
hypertension. The aim of our studies was to investigate the effects of
chronic hematocrit value changes on arterial blood pressure and
kidney function in genetically induced hypertension. To this end, we
studied the effects of several interventions, designed to
increase/decrease hematocrit, on hemodynamic parameters, vascular
reactivity, glomerular filtration and renal function curve in spontaneously
hypertensive rats (SHR). Results of our study show that chronic
hematocrit value elevation increases blood pressure and peripheral
vascular resistance in SHR. On the other hand, chronic hematocrit
lowering elucidates blood pressure and peripheral vascular resistance
decrease followed by cardiac output rising. Both hematocrit value
changes significantly reduce vasodilatory vascular response.
Hematocrit lowering induces acute renal failure. Sodium excretion is
shifted to higher blood pressure values in high hematocrit value
animals and opposite - lower blood pressure values in low hematocrit
value animals. Repeated transfusions develop salt sensitive malignant
hypertension in SHR. Further studies are necessary to evaluate the
degree of kidney damage after chronic hematocrit value changes in
SHR.
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INTRODUCTION
Hematocrit (Hct) is the proportion of blood volume that is occupied by red
blood cells. In humans it is normally within the range from 38% to 48%. The role of
hematocrit in the regulation of blood pressure has been seen in the highlight of
Whitaker and Winton (1933), the classical concept being that there is a direct
relationship between hematocrit value and blood viscosity. Nevertheless,
considering Poiseuille’s equation (Burton, 1965) blood pressure is directly
proportional to viscosity. Numerous studies in normotensive animals have shown
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that both acute and chronic wide-range changes in hematocrit value do not
influence blood pressure (Hatcher et al., 1954; Richardson et al., 1959; Guyton et
al., 1961; Murray et al., 1963; Mc Donald et al., 1974). Experimental induced
hematocrit value changes in these studies were found to be associated with
similar changes in total peripheral resistance and a reciprocal change in both
venous return and cardiac output, so blood pressure remains unchanged.
Studies of acute normovolemic anemia also showed an increase in cardiac output
as a compensatory response (Champion et al., 2011). In opposite, studies in
hypertensive humans and animals (Letcher et al., 1981; Declerk et al., 1980) had
shown increased blood viscosity in direct relation with essential hypertension.
Przybylski (Przybylski et al., 1997) showed an increased erythrocyte number and
concentration of hemoglobin (Hb) in 14 weeks old spontaneously hypertensive
rats (SHR). The results of the Strong Heart Study in American Indians showed a
clear positive relationship between hypertension and blood viscosity (de Simone
et al., 2005). Results of Su{i} (Su{i} et al., 1982) implicated that heparin induced
hematocrit lowering was followed by decreasing arterial blood pressure, without
changes in plasma volume in SHR.
Beside the effects on blood viscosity, hematocrit value changes can
influence blood pressure via nitric oxide (NO) production. The mechanism of this
effect is believed to be due to the essentially irreversible binding of the vasodilator
NO by the heme of Hb (Schultz et al., 1993). In physiological conditions,
increased blood viscosity induces vasodilatation which neutralizes
haemodynamic changes. In the healthy population Hct presents a variability
which is not reflected by the variability of blood pressure. This is due to a
regulatory process at the level of endothelium, whereby the increase of Hct leads
to increased shear stress and the production of the vasodilator nitric oxide
(Salazar Vazquez et al., 2010). On the other hand, there is reduced vasodilatation
in SHR, due to disturbance of vasoconstriction/vasodilation mechanisms and
vascular damages, which taken together lead to increased sensitivity for the
change in blood viscosity (Koller et al., 1996). In the kidney, hematocrit value
changes elucidate disturbances in renal haemodymanic, glomerular filtration and
postglomerular oncotic pressure, shift renal function curve and lead to changes in
arterial pressure (Guyton, 1987). Also, many studies have shown nephrotoxicity
potential of Hb due to tubular obstruction, free radical production and
vasoconstriction (Jaenike, 1967; Shah and Walker, 1988; Thompson et al., 1994).
The aim of our study was to investigate the effects of chronic hematorcrit
value changes on arterial blood pressure and kidney function. To this end, we
studied the effects of several interventions designed to increase and/or decrease
hematocrit values on hemodynamic parameters, vascular reactivity, glomerular
filtration and renal function curve in SHR.
MATERIALS AND METHODS
Materials
Female adult SHR, weighted about 300 g, were bred at the Institute for
Medical Research, Belgrade and fed on a standard chow for laboratory rats
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(Veterinarski zavod, Subotica, Serbia). All animal experiments were conducted in
accordance with local institutional guidelines for the care and use of laboratory
animals. The investigation also conforms to the principles and guidelines of the
Canadian Council on Animal Care (CCAC).
Experimental protocol
Three separate experimental studies were performed: haemodynamic
measurements, vascular response study and renal function curve - glomerular
filtration study. In all mentioned studies the animals were divided in three groups:
control non-treated SHR with normal hematocrit (Control); SHR with high
hematocrit (HighHct) and SHR with low hematocrit (LowHct). In the HighHct
group repeated transfusions of homologous red blood cells (2 mL i.p.) were given
three times weekly during the 4 week treatment period. For hematocrit lowering,
hemolytic phenyl hydrazine (3 mg/100 g b.m.) was given to the LowHct group
three times a week during the 4 week treatment period.
Haemodynamic measurements
Haemodynamic parameters were measured in 24 animals after the 4 week
treatment period. All animals were anaesthetised (35 mg/kg sodium
pentobarbital; i.p.) and hematocrit samples were collected. Mean arterial
pressure (MAP) was determined directly through a femoral artery catheter (PE-50,
Clay-Adams, Parsippany, NY, USA), with a low-volume displacement transducer
(P23 Db, Statham, Oxnard, CA, USA) and recorded on a direct writing recorder.
Cardiac output (CO) was determined by modified Coleman’s application of the
dye dilution technique as previously described (Coleman, 1974). Total vascular
resistance (TVR) was calculated by dividing MAP by CO and expressed as mmHg
min 100 g/mL.
Vascular response study
There were 62 animals included in the vascular response study. Each
animal was canulated trough the jugular vein and injected with three doses of
acetyl-choline (Ach) respectively: 0.25; 0.50; 0.75 µg/kg b.w. MAP was monitored
for each dose. After that, nitric oxide (NO) synthesis inhibitor L-NAME (NG-L-
Arginine Methyl Ester, Sigma; 10 mg/kg b.w. i.v.) was given to randomly selected
animals from each group: Low Hct + L-NAME (n=10); Control + L-NAME (n=11);
High Hct + L-NAME (n=8). MAP rising was registered 30 minutes after L-NAME
injection. Further, three previously mentioned doses of Ach were given to L-NAME
pretreated animals and MAP was recorded again.
Renal function curve and glomerular filtration study
The study was performed in 24 animals. Animals were drinking tap water
during the first 14 days. Systolic arterial pressure (SAP) and urinary
concentrations of sodium (Na+) (IL 943-flame photometer, Instrumentation
Laboratory, Milan, Italy) were measured at the end of the treatment. In the next two
weeks, animals were drinking saline (1% NaCl dissolved in drinking water) and
SAP and urinary Na+ concentration were measured at the end of the treatment. At
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the end of the study, urine and blood samples were collected and urinary and
plasma concentrations of creatinine were determined. Glomerular filtration (GFR;
endogenous creatinine clearance) was estimated using standard creatinine
clearance formula.
Statistical analyses
Results are expressed as mean ± S.E.M. One-way analysis of variance
(ANOVA) was applied. When the ANOVA results were significant, Bonferroni’s t-
test was used to determine the level of significance and a p value <0.05 was
considered to be significant (Primer of Biostatistics, by Stanton A. Glanz).
RESULTS
Hematocrit values and hemodynamic parameters
Hematocrit was significantly lower in LowHct group and higher in HighHct
group in comparison to the Control (Figure 1). MAP showed a significant
decrease in the LowHct vs. Control group (Figure 2). Opposite, MAP was
significantly higher in HighHct group vs. Control. CO was significantly higher in
LowHct vs. Control (Figure 2). TVR showed a significant decrease in LowHct vs.
Control group (Figure 2). However, TVR was significantly higher in HighHct group
vs. Control.
Vascular reactivity
Chronic hematocrit value changes modify acetyl-choline induced
vasodilatation in SHR. Both, animals with high, as well as low hematocrit, showed
significantly (p<0.05) blunted acetyl-choline induced relaxation in comparison to
control animals (Figure 3). MAP was increased in all treated groups after single
bolus injection of L-NAME, but only in HighHct group was significantly higher in
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Figure 1. Hematocrit values in experimental groups; n-number of animals
comparison to the control. Vasodilatation response to acetyl-choline after L-NAME
injection was significantly (p<0.05) blunted in rats with high hematocrit in
comparison to control animals (Figure 3).
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Figure 2. Hemodynamic parameters in experimental groups; n-number of animals
Figure 3. Acetyl-choline induced mean arterial pressure (MAP) dropping in SHR before and
after L-NAME treatment; n-number of animals
Glomerular filtration and renal function curve
GFR significantly (p<0.05) dropped in the LowHct group (Figure 4). Renal
function curves are shown in Figure 5. Renal function curve of SHR with a normal
hematocrit value is almost vertically positioned and right-shifted in comparison to
the standard normotensive renal function curve. Renal function curve of the
HighHct group is right directed and renal function curve of the animals with low
hematocrit value was significantly left-shifted in comparison to control animals.
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Figure 5. Renal function curves in experimental groups; n-number of animals
Figure 4. Glomerular filtration in experimental groups; n-number of animals
DISCUSSION
Results of the present study demonstrate that chronic hematocrit value
changes alter blood pressure in SHR. A decreased hematocrit induces CO rise
followed by TVR and MAP decrease. On the other hand, increasing hematocrit
value induces CO decrease and further TVR and MAP increase. Dintefass and
Girolami (1978) have shown a positive correlation among diastolic blood pressure
and blood viscosity in patients with a high hematocrit (46%). Isovolemic
haemodylution leads to a decrease in hematocrit and plasma fibrinogen, to
reduction of blood viscosity and finally to a decrease in arterial blood pressure
(Sieffge et al., 1981). Also, studies of Su{i} (Su{i} et al., 1982; 1988; 1992) showed
that heparin or phenylhydrazine induced lowering of hematocrit value, followed
by arterial blood pressure decrease.
Strazzullo et al. (1990) reported increased both hematocrit and hemoglobin
values in hypertensive patients. A clear positive relationship between
hypertension and blood viscosity was described in the Strong Heart Study in
American Indians (de Simone et al., 2005). A four year follow up study of Mandal et
al. (1993) showed that decreasing of blood viscosity (induced by hematocrit
lowering) participates in diastolic blood pressure reduction in hypertensive
patients receiving 50 mg of hydrochlorothiazide and there was no change in
kidney function. Our results are in accordance to the findings of Mayer et al.
(1988) that increase in hematocrit values induces high blood viscosity followed by
CO lowering, increasing vascular resistance and finally arterial hypertension.
Besides, vascular endothelial cells produce the strong endogenous vasodilator
molecule NO (Lüscher TF, 1990) which is occupied by an excess of Hb (Schultz et
al., 1993) leading to vasoconstriction and blood pressure elevation.
In the present study, chronic hematocrit value elevation significantly blunts
Ach induced vasodilatation. Nakai et al. (1996) showed that repeated transfusions
increase plasma hemoglobin and inhibit circulating NO, opposite to synthetic
hemoglobin products which can inhibit both circulating and mio-intimal blood
vessel NO. There are two different ways of Hb induced NO inactivation. First,
oxyhemoglobin reacts with NO quickly (in 100 ms) producing nitrite ions and
methemoglobin (Hb-O2 + NO  NO3–) and second, deoxyhemoglobin binds NO
producing NO-hemoglobin. The net result of both actions is decreased NO
bioavailability and vasoconstriction (Schultz et al., 1993). Rioux et al. (1994)
showed that Hb can neutralize Ach via direct stimulation of cholinesterase activity.
Unexpectedly, hematocrit value lowering significantly blunted Ach induced
vasodilatation in our study. It’s well known that hypoxia induces elevation in
endothelium derived NO production, thus resulting in vasodilatation (Kam and
Govender, 1994). Regarding that, it’s reasonable to expect a stronger Ach
induced vasodilatatory response in low hematocrit animals. Our results could be
explained by the study of Bassenge et al. (1996) that hypoxia due to low
hematocrit/hemoglobin concentration stimulates macrophage inducible NO
sinthase (iNOS) which further inhibits expression of endothelial NO sinthase
(eNOS) - mediator of Ach induced vasodilatatory response. On the other hand,
phenylhydrazine as a toxic and hemolytic agent (Williams, 1990) could damage
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both endothelial cells and receptors, therefore disturbs vascular response. Both,
L-NAME induced MAP elevation and blunted Ach induced vascular response
correlate our results with the study of Sharma et al. (1995) which implies
synergism of hemoglobin induced NO inhibition and L-NAME vascular effects.
Dramatically reduced GRF in LowHct group indicates that these animals
have developed acute renal failure (ARF). There are several factors involved in the
initiation and maintenance of ARF: decrease of glomerular capillary permeability,
back-leak of glomerular filtrate, tubular obstruction and intrarenal
vasoconstriction (Nissenson, 1998). Many haemolytic agents, among them
phenyl hydrazine and its derivates can induce ARF (Stefanovi}, 1989). There are
three possible mechanisms of hemoglobin induced kidney injury: tubular
obstruction due to macromolecular precipitation of hem protein (Zager and
Gamelin, 1989); free radical damages of kidney epithelial cells due to oxidation of
iron (Paller, 1988) and ischemic injury due to NO induced hem inactivation
(Moncada et al., 1991). However, detailed histopathological analyses is needed to
evaluate the degree of renal damage in our study.
It is not easy to define exactly the reasons for disturbed salt and water
excretion in hypertensive humans and animals. Kimura and Brenner (1995)
suggested increased pregolmerular vascular resistance as a mechanism of not
salt-dependent hypertension. In salt-dependent hypertension, these authors
proposed lowering of kidney ultrafiltration coefficient and increased tubular
sodium reabsorption as mechanisms of developing hypertension. Hu and
Manning (1995) showed disturbed sodium excretion, decreased excretion of
nitrates and nitrites, right shifted renal function curve and blood pressure
elevation in salt sensitive Dahl rats. After NO donor infusion (L-Arginine;
4 mg/kg/min) there was an increased excretion of nitrates and nitrites, left shifting
of the renal function curve and returning of blood pressure. This implies that
diminished NO production in salt sensitive rats results in right-shifted renal
function curve and hypertension developing without changed sodium excretion.
Also, results of Boegehold et al. (1992) have shown that the non-hypertensive
dose of L-NAME (0.1 µg/kg/min), competitive inhibitor of enzyme NO sinthase,
induces blood pressure elevation after salt loading (300 meq/day). Taken
together, it can be conclude that diminished NO bioavailability in the kidney
reduces sodium and water excretion after long-lasting salt loading resulting in salt
sensitive hypertension. Also, results of our study lead us to conclude that NO
induced hem inactivation could be responsible for blood pressure salt-sensitivity
in HighHct group.
In summary, results of our study show that chronic hematocrit value
elevation participates in blood pressure and peripheral vascular resistance
increasing SHR. On the other hand, chronic hematocrit value lowering elucidates
blood pressure and peripheral vascular resistance decrease followed by CO rise.
Both hematocrit value changes significantly reduce vasodilatory response, but
NO dependent vasodilatory response is significantly blunted only in high
hematocrit animals. Hematocrit lowering induces a decline in glomerular filtration
and plasma creatinine elevation leading to acute renal failure. Sodium excretion is
shifted to higher blood pressure values in high hematocrit animals and opposite -
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to lower blood pressure values in low hematocrit animals. Repeated transfusions
develop salt sensitive malignant hypertension in SHR. Further study is necessary
to evaluate the degree of kidney damages after chronic hematocrit value changes
in SHR.
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UTICAJ HRONI^NE PROMENE VREDNOSTI HEMATOKRITA NA KRVNI PRITISAK I
GLOMERULSKU FILTRACIJU KOD PACOVA SA URO\ENOM HIPERTENZIJOM
MILANOVI] S, JOVOVI] \UR\ICA, MIHAILOVI]-STANOJEVI] NEVENA,
GRUJI] MILANOVI] JELICA, IVANOV M, KARANOVI] DANIJELA i MILORADOVI] Z
SADR@AJ
Brojna ispitivanja izvedena na `ivotinjama i ljudima su ukazala da je pove}a-
nje viskoznosti krvi u direktnoj vezi sa hipertenzijom. Cilj na{e studije je bio da se
istra`i uticaj promene vrednosti hematokrita (Hct) na krvni pritisak i funkciju bu-
brega u uro|enoj hipertenziji. U tom cilju, istra`ivan je uticaj hroni~nog pove}anja
ili smanjenja vrednosti Hct na hemodinamske parametre, vaskularnu reaktivnost,
glomerulsku filtraciju i krivu bubre`ne funkcije kod pacova sa uro|enom hiperten-
zijom (SHR). Rezultati na{e studije su ukazali da hroni~no pove}anje vrednosti
Hct dovodi do pove}anja arterijskog krvnog pritiska (AKP) i perifernog vaskular-
nog otpora (PVO) kod SHR . Nasuprot tome, hroni~no smanjenje vrednosti Hct
dovodi do smanjenja AKP i PVO, pra}enih pove}anjem minutnog volumena srca.
Obe promene vrednosti Hct dovode do smanjenja vaskularne reaktivnosti.
Hroni~no smanjenje vrednosti Hct izaziva nastanak akutne bubre`ne insuficijen-
cije. Ekskrecija natrijuma je pomerena ka ve}im vrednostima krvnog pritiska kod
pacova sa pove}anim vrednostima Hct, a ka ni`im kod pacova sa sni`enim vred-
nostima Hct. Hroni~no pove}anje vrednosti Hct dovodi do razvoja maligne hiper-
tenzije kod SHR. Potrebne su dalje studije da bi se utvrdio ta~an stepen i priroda
o{te}enja bubrega nakon hroni~ne promene vrednosti Hct.
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